Blog Read the latest perspectives from our team of subject matter experts and others How Incyte Is Advancing Clinical Trial DiversityDiversity in clinical trials is more than just a regulatory requirement—it’s a critical component of equitable healthcare. Ensuring that trial participants reflect the real-world patient population leads to more… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact HCP Volunteers KOL Engagement Patient Representation Provider Data Research Post Industries:Commercialization Global Impact Health Plans & Digital Health Pharmaceutical & Biotechnology Provider Data Research KOL EngagementGoing with the Digital FlowEven now: two and a half years later, the COVID-19 pandemic continues to have a substantial impact on the activities of Medical Science Liaisons (MSLs), including access to Key… Continue reading → Read the article Drug DevelopmentPatient RepresentationThe ABCs (and Ds) of Clinical Trial DiversityWhen the FDA mandated guidelines earlier this year for broader clinical trial diversity and inclusion, it brought a long-standing challenge in pharma and life sciences into the spotlight. Here, Alexandra… Continue reading → Read the articleno Drug DevelopmentKOL EngagementPatient RepresentationA New Reflection on Pharma, Research, and Patient CarePharma has long existed in elevated, prestigious academic institutions: ivory towers of reputable and revered centers of excellence famous for disseminating the latest in clinical research and medical breakthroughs.… Continue reading → Read the article Drug DevelopmentKOL EngagementH1 Announces Partnership with Society for Clinical Research SitesThe Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the… Continue reading → Read the article CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataResearchThe Evolution of H1’s Core ValuesI remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading → Read the article Drug DevelopmentPatient RepresentationEquitable Healthcare Starts with Medical AffairsBecause they serve as the bridge between research and commercial functions of life sciences companies, medical affairs can drive equity in clinical trials by proactively engaging with a diverse set… Continue reading → Read the article«‹6789101112›»
